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ABSTRACT 
 
Background:  
Few clinical diagnostic tools to rule in or rule out depression have been validated in primary 
care. From a previous systematic review study, it became clear that in terms of research, a 
validated clinical diagnostic tool (effective, reliable and usable) was needed by European 
General Practitioner (GP) investigators in order to include patients for research studies in 
daily practice care and for cross-sectional studies between psychiatrists and GPs. 
 
Research question: Which clinical diagnostic tool for depression, validated against psychiatric 
examination according to DSM for primary care adult patients, do GPs select as the best for 
use in clinical research, taking into account the combination of efficiency, reliability and 
usability? 
  
Method: A systematic literature review followed by a consensus procedure in two Delphi 
rounds with an expert panel meeting inserted (i.e. a RAND Appropriateness Method). For the 
experts’ group inclusion researchers and/or general practitioners (GPs) from different 
European countries were carefully included. The systematic literature review extracted tools 
validated against DSM as standard diagnostic criteria. The effectiveness criterion used was 
The Youden index was used as an effectiveness criterion and Cronbach’s alpha as the 
criterion of reliability. Usability data were extracted from the literature (structure, method of 
collection, duration...).  
 
Results: The literature review compared 7 diagnostic tools validated against psychiatric 
examination according to DSM. In the first Delphi round, two instruments were considered 
sufficiently effective and reliable for use: the Hospital Anxiety and Depression Scale (HADS) 
and the Hopkins Symptoms Checklist-25 (HSCL-25). Usability was tested during the expert 
panel meeting. In the second Delphi round, experts selected the HSCL-25 according to 3 
criteria: efficiency, reliability and usability and it was this last criterion that was considered 
particularly effective for HSCL-25 when compared with the HADS.  
 
Conclusion: A multicultural consensus on one diagnostic tool for depression has been 
obtained: the clinical tool HSCL-25. This tool will provide the opportunity to select 
homogeneous populations across Europe to undertake collaborative clinical research in daily 
practice, between GPs and between GPs and psychiatrists. 
 
 
BACKGROUND 
 
Depression is the leading cause of disability throughout the world, affecting 350 million 
people. Primary care is a strategic place for screening, diagnosis, and treatment of depressive 
disorders [1]. Depressive disorders will increase its already high burden on OCDE countries 
by 2030 [2]. For the patient, depression causes a significant decline in his/her ability to cope 
and aggravates his/her psychological distress [3]. Risk of suicide, closely linked to 
depression, is a dramatic potential consequence of depressive disorders [4][5]. Depression is a 
recurrent problem for public health care, because of its social and economic consequences [6]. 
Several studies stress that an early diagnosis is very important; it may decrease the duration 
and impact of the depression [7].  
 
We have a triple challenge: 
- try to improve in daily practice this early detection of depression 
- to provide simple and effective means that allow medical research in daily practice. 
- agreeing to use this tool, regardless of the countries. 
 
In general practice: 
 
General Practitioners (GPs) are the first port of call in the health care system in most 
European countries [8][9]. Diagnosing major depression has a high specificity, but a low 
sensitivity in Primary Care Medicine [10]. For 25 years, academics in psychiatry and primary 
care assume that only 10–50% of depressed patients are adequately treated, primarily because 
of the failure to recognize depression. Those facts could be related to the patient’s reluctance 
to express their symptoms and the variability of the symptomatology of depression [11]. 
However, another barrier to recognition is that the traditional psychiatric interview is 
impractical in primary care settings because it takes too much time [12]. In this context, some 
tools can support physicians in their diagnosis of depression but most tools are not suitable for 
primary care use. In primary care, the time of medical consultation is short. An efficient tool 
has to be sensible and usable to facilitate depression diagnosis. Moreover, a good tool is 
highly needed for pragmatic research in primary care. [12]  
 
In medical research: 
 
There are common selection criteria: efficiency, stability and usability. Moreover, the tool 
must be consensually accepted by researchers and have face validity. It must be validated to 
predict psychiatric referrals well and should be accepted by the two professional communities 
[13]. These are  important conditions for  pragmatic research in primary care. [12] 
 
In collaborative research: 
 
The purpose was also to develop collaborative research about depression, in primary care 
throughout Europe. Research networks such as EGPRN need reliable, efficient and usable 
tools which take into account cultural and linguistic differences [14]. With this common goal, 
European primary care researchers decided to work together to find such a tool. International 
experts from different cultures, speaking different languages and with different health systems 
have to seek consensus [15]. These tools have to be acceptable and informative for both GPs 
and for secondary care (Psychiatrist, Psychologist) and to improve their collaboration 
[13][16]. 
 
In our recent systematic review of literature covering the last fifteen years, we found seven 
tools for psychiatric examination, which were validated according to the major depression 
criteria in DSM IV-5, usable in primary care research, and conceptually understandable by 
GPs and psychiatrists [17].  
 
Based on these criteria, our research question was what consensual diagnostic tool for 
depression, GPs researchers would select for use in clinical research as the most efficient, 
reliable and feasible.? 
 
  
METHOD 
 
Design: a RAND/UCLA process to define the best depression tool for general  practice 
research 
 
EGPRN has developed a research agenda in 2010 to facilitate a common structured approach. 
Through the EGPRN, European primary care researchers have been recruited from national 
experts. A network of researchers was created with this objective: to find a cross-sectional 
diagnostic tool usable by both primary care and psychiatry, allowing collaborative research 
between countries of different cultures and languages.  Experts had to be academic 
researchers or teachers, FPs and fluent in English.  
 
A systematic literature review covering the last fifteen years, found seven tools usable in 
primary care research, conceptually understandable by GPs and psychiatrists [17].  Their 
psychometric properties, sensitivity (Se), specificity (Sp), positive and negative predictive 
values (PPV, NPV) do not vary sufficiently to allow statistical comparison, however.  The 
study populations were different, and the reliability and usable qualities of each tool had to be 
considered as insufficient researched?.  
 
To come up with the best possible tool, we needed an evaluation and selection process which 
would ensure experts can work independently but with opportunities for discussion. [18]. The 
RAND / UCLA process ias a consensus method which combines independence and debate 
among experts and was selected by the study’s scientific committee as the best possible 
research process for this study [19].  
 
The RAND/UCLA Appropriateness Method (RAM) combines the qualities of the Delphi 
process [20] and the nominal group [21]. Developed in the eighties, it allows a consensual 
choice in comparing complex processes. In medical research it has been used to measure the 
quality of care procedure [19]. It combines, after a literature review, two Delphi rounds with a 
meeting of experts. This process combines the advantages of the focus group 
(communication, face-to-face debate and interaction about ratings) and the quality of Delphi 
(independent evaluation by experts, working blind, in order to remove any leader effect). 
Seven to fifteen experts are necessary to achieve RAM [22][19]. The quality level of RAM is 
increased when they use in their procedure the results of a systematic review instead of a 
simple review. 
 
. 
We followed 3 steps.  
 
First step: 
 
The study started by a Delphi: (i) in order to eliminate the least efficient tool, (ii) in order to 
keep the more reliable. 
Each expert received: introduction letter, study flow chart, study method, efficiency and 
sample and reliability data, consent form. They had to rate the efficiency and reliability of 
each tool on a 9 point Likert scale [23]: 
- Is this tool an effective aid to diagnose depression in primary care?  
- Is this tool a reliable aid to diagnose depression in primary care?  
 
Consensus was defined as at least 70% of the experts rating questions at 7 or above [22]. A 
tool was selected if it had a result greater than 70% of the two questions.   
Commentaries were collected in order to structure the experts’ meeting discussion. 
 
Second step:  
The 2nd step (experts’ meeting) ensured the results of the 1st step and debate, without voting, 
the usable features of selected tools. 
Experts were equipped with the following resources:   
 - a reminder about the methodology of the study 
- the results of the first round, including all the experts’ comments. 
- details about the usable features of each tool 
- bibliography data  
 - a list of additional information to be completed by the experts. 
- the individual results from each expert and his/her comments. 
- 3 notation grids showing the usable features of each tool. One had been filled in at 
the beginning, another after testing tools and the last one at the end of the experts’ meeting. 
All grids were collected and kept by the study committee at the end of the experts’ meeting. 
 
The experts were invited to discuss the results of the first round on efficiency and reliability 
and whether they agreed with them or not. If more than 70% of the experts agreed with the 
results of the first round Delphi, consensus on selected tools was achieved. 
 
The tools selected were then presented. The experts were invited to read all documents and to 
rate the following statements: 
- "This tool is easy to use in family practice". 
- "This tool could easily be introduced during a consultation". 
- "This tool could be understood by patients". 
- "I like this tool". 
- "Patients could be surprised by this tool". 
 
Then experts were invited, working in pairs, to discuss and test the tools face-to-face. 
Afterwards each expert was asked individually to rate on a 9 point Likert scale the tools using 
the same grid, in order to assess whether testing the tools had modified their judgment. Then a 
discussion about the feasibility of the selected tool was held among all the experts. The 
moderator focused on improving the experts’ personal expression. The meeting ended with 
final quotations using the same grid for each tool. The entire meeting was recorded in both 
video format and as an audio file for ultimate quality control. 
 
No final consensus was required at the end of the meeting, which is in line with the RAM 
instructions. 
 
Third step:  
The goal of the 3rd step was to vote, in the light of the results of the 1st et 2nd steps, for the best 
tool in terms of efficiency, reliability and usability. 
 
At the end of the experts’ meeting, all discussions were transcribed. Each expert received the 
transcript independently, incorporated into a synthesis document. 
 
This synthesis document included: 
- - a reminder on the purpose of the study. 
- - the results of the systematic literature review  
- - a reminder of the methodology and the results of the first Delphi round. 
- - a reminder of efficiency, reliability and sample data of the tools selected at the end of 
the meeting. 
- - the full transcript of the discussion among experts with a synthesis of the key points 
of the discussion. 
- - the distribution of the results of the latest listing of five statements for each of the 
selected tools at the end of the discussion. 
 
The final question was: “Which is the most appropriate tool for the diagnosis of depression in 
adult patients, in Family practice, in Europe, in terms of its Efficiency, Reproducibility and 
Usability ". The experts were asked to vote on each tool and to comment on their response. 
 
 
RESULTS 
 
Eleven experts from 8 European countries participated in the RAND / UCLA. They were all 
GPs, EGPRN members and fluent in English. The panel was composed of 9 women and 2 
men. Of the 11 experts 9 practised in urban areas of more than 5,000 inhabitants and 2 
worked in urban areas with 2,000 to 5,000 inhabitants. (Table1). 
 
  
Table 1: Expert panel- characteristics of participants  
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1 F 
Spain 
(Galicia) 
Teacher/ 
Researcher 
>5000 
FPs group 
office 
15 20 14 
2 F 
Spain 
(Cataluña) 
Teacher/ 
Researcher 
>5000 
FPs group 
office 
13 22 25 
3 F Greece  
Teacher/ 
Researcher 
>5000 
FPs and 
paramedic 
group office 
14 30 18 
4 M Italy  Researcher >5000 
FPs group 
office 
23 7 6 
5 F Germany  Researcher 
2000 to 
5000 
Practice 
stop since 
2 years 
19 23 5 
6 M Poland  
Teacher/ 
Researcher 
>5000 
FPs group 
office 
20 30 12 
7 F Croatia  
Teacher/ 
Researcher 
>5000 Alone 6 20 12 
8 F Bosnia  
Teacher/ 
Researcher 
2000 to 
5000 
FPs group 
office 
2 22 12 
9 F Croatia  
Teacher/ 
Researcher 
>5000 
FPs group 
office 
18 30 20 
10 F Bulgaria  
Teacher/ 
Researcher 
>5000 
FPs group 
office 
9 14 12 
11 F Germany  Researcher >5000 
FPs group 
office 
4 18 7 
 
* PubMed Database 
The tools selected by the literature review were: GDS-5, 15 and 30 items (Geriatric 
Depression Scale with 5, 15 and 30 items), the HSCL-25 (Hopkins Symptoms Checklist with 
25 items), the HADS (Hospital Anxiety Depression Scale), the PSC-51 (physical symptom 
checklist in 51 items), and the CES-DR (Center for Epidemiologic Studies Depression Scale-
Revised). 
 
 
  
First step Results: 
  
Table 2: Results of the first Delphi round 
  
  
Efficiency Reliability Conclusion 
  
Median 
(average) 
Scores >6 
as 
percentage  
Median 
(average) 
Scores >6 
as 
percentage  
  
PSC 51 5 (5) 0 7 (6.9) 80 
Eliminated 
Tools: reliable 
but not 
efficient 
GDS 30 4 (3.6) 0 7 (7.3) 90 
CES DR 4 (3.8) 0 8 (8.1) 90 
GDS 15 8 (7.7) 100 6 (6.6) 0 Eliminated 
tools: efficient 
but not 
reliable 
GDS 5 7 (7.4) 91 2 (1.8) 0 
HADS 7 (7.2) 90.9 7 (7.4) 100 Selected 
tools: 
considered 
both efficient 
and reliable 
HSCL 25 7.5 (7.3) 82 9 (8.5) 100 
 
 
PSC-51 and GDS-30 and CES-DR were eliminated for lack of efficiency. The main reasons 
were low Youden index, selection bias in studies, too many lost during follow up. GDS-15 
and GDS-5 were considered efficient but unreliable. The main reasons were: disparity in 
Cronbach’s alpha value for GDS-15, only a reliability study for GDS-5. HADS and HSCL-25 
were considered efficient and reliable. Population and sample were considered of lower 
quality for HSCL-25 compared with HADS. 
 
Second step results:  
 
8 experts participated actively in the whole process and had the opportunity to express their 
opinions. 6/8 of the experts agreed with the results of the first Delphi round and confirmed 
that HSCL-25 and HADS were the best-validated tools in terms of efficiency and reliability. 
 
Table 3: The development of quotations during the experts’ meeting 
 
Tools 
Statements put to the 
experts 
Scores >6 as percentage  on a 9 point Likert scale 
First quotation:  
After reading only 
usable data 
Second quotation:  
After testing and 
discussion of the 
questionnaires in pairs 
Third quotation:  
After discussion 
among all the experts 
HADS 
This tool is easy to use in 
FP’s practice 
50 12,5 12,5 
This tool could easily be 
introduced during a 
consultation 
25 12,5 12,5 
This tool could be 
understood by patients 
37,5 12,5 12,5 
I like this tool 25 12,5 12,5 
Patients could be 
surprised by this tool 
75 62,5 62,5 
HSCL-25 
This tool is easy to use in 
FP’s practice 
87,5 100 100 
This tool could easily be 
introduced during a 
consultation 
87,5 75 75 
This tool could be 
understood by patients 
87,5 62,5 75 
I like this tool 87,5 87,5 87,5 
Patients could be 
surprised by this tool 
25 0 0 
 
Before the usability was tested, the experts favoured HADS, but their individual points of 
view were modified after testing HSCL-25 face-to-face (Table 3). No consensus was collected 
at the end of the meeting on any single tool, in line with the RAM instructions. 
 
 
The whole comments were collected and they were returned to the experts in the document 
that were sent to them for the 3rd phase (as example): 
 
For HADS: 
- The questions are difficult for patients to understand; the answers are difficult for patients 
because they correspond to positive and negative choices; this tool is too long. 
- The answers require explanation and reformulation for patients. 
- HADS seems best for psychotherapists and HSCL-25 looks better for patients. 
 
For HSCL-25: 
- It’s a self-administered, easy tool and seems to be the most transferable to DSM; the results 
are detailed. 
- The answers are on 1 to 4 Likert scale; the responses are recorded by checking on a table; 
the answers are simpler than HADS. 
- HSCL-25 has already been tested across Europe, specifically among refugee populations; it 
is usable for both screening and diagnosis 
 
 
Third step results: 
 
To the 8 experts who participated in the whole procedure, they were asked to vote by 
answering the following question: 
"Which is the most appropriate tool to diagnose depression in adult patients in Family 
practice, in Europe, in terms of its effectiveness, its reliability and its ease of use?" 
 
- 6/8 of the experts answered, "In my opinion, HSCL-25 is the most appropriate tool to 
diagnose depression in Primary Care practice." 
- 2/8 of the experts answered, "In my opinion, HADS is the most appropriate tool to 
diagnose depression in Primary Care practice." 
 
 
No comments were received for this final step, however, the experts gave, as example: 
- "After analysing all the psychometric properties, the most useful test in primary care in 
many countries in Europe, with numerous cultural variations is HSCL-25." 
- "In my view, HSCL-25 is the easiest to use in practice and the easiest for patients to 
understand." 
- "In terms of efficiency, reliability and usability, HSCL-25 is my first choice. However, I must 
add that HADS is the best known and most commonly applied tool in clinical practice as well 
as in scientific discussions between different medical and non-medical professionals. In 
communication and discussion with our colleagues, it is crucial for the monitoring of 
depressed patients; we have to think about this if we choose HSCL-25. " 
- "HSCL-25: Simple, detailed enough for the diagnosis, administration time low, easy to 
understand." 
 
 
DISCUSSION 
 
In our study, the HSCL 25 appeared to be the most interesting tool for diagnosing depression 
in primary care. Most international experts stated that HSCL-25 was the most appropriate 
tool, in terms of its efficiency, reliability and feasibility. We used a RAND/UCLA 
methodology, based on an systematic literature review [17] and a rapid review [24]. This 
method is consequently a modified RAM of higher quality than the original one that requires 
a non-systematic literature review. In the health care and especially in primary care, feasibility 
of a tool is an important criterion in establishing or maintaining a relationship between patient 
and practitioner. Researchers demonstrated, by this consensus process, how feasibility was a 
decisive factor in choosing a tool with a view to future research in primary care [25] .  
 
The present study confirmed the usefulness and relevance of the HSCL-25 in primary care 
research. Originally developed for non-traumatized populations, it was later adapted and 
widely used for evaluation among traumatized populations [26]. A 2009 study in Sweden 
showed that HSCL-25 had comparable results between subjects from a Scandinavian 
population and subjects from a population of immigrants from the Middle East [27]. This 
study suggested that HSCL-25 could be used for population surveys within multicultural 
groups in western Europe [28]. HSCL-25 has been used and tested many times in primary 
care situations, compared with the diagnosis of psychiatric disorder carried out by Primary 
Care practitioners [29][30]. It has robust efficiency and reliability scores [31–33] . 
 
The HADS is a  tool that has been widely used over a long time for clinical purposes and for 
research [34].  It is widely used and has been translated into several languages [35]. It is a 
usable  and validated for use in primary care [36, 37]. It has proved its value in the 
communication it allows?  between medical specialities [36]. Nevertheless this tool seems 
complicated for research purposes in primary care daily practice. Its psychometric qualities 
are more suitable for screening than as ‘a case-identifier’ tool for depression [38]. 
 
The GDS or GDS-30 was developed specifically to detect depression in elderly patients [39]. 
GDS had been rejected in 2 shorter versions of the tool: GDS-15 and GDS-5. The efficiency 
of those versions was acceptable but the reliability was not. The shorter the version, the  
lower the reliability [40–44]. Experts did not select these scales because their efficiency and 
reliability data were inadequate. The Youden index for the GDS-30, validated against DSM-
IV, was poor. The Cronbach’s alpha was too low to allow GDS-15 and GDS-5 to be selected. 
 
PSC-51 and CES-DR were considered but the Youden Index score was too low and they were 
quickly discarded [45]. 
 
 
Through this consensus procedure, we suggest the HSCL-25  as an efficient, reliable and 
easy-to-use tool with good psychometric qualities. This confirms its value in clinical use and 
for research. Today in Europe, the movement of refugee populations is important. HSCL-25 
has already been used in clinical settings both for refugee and general populations, [46, 47]. 
This has already allowed English-speaking populations and practitioners to use it.  For non-
English speaking populations, translations will be of great importance. 
The usability of HSCL-25 will reassure students of the feasibility of such tests in primary 
care. Teachers could use this validated tool as the basis of their courses for depression 
diagnosis in FM. They should have enough confidence in the reliability and efficiency data to 
teach it to their students. 
An efficient, reliable and usable tool such as HSCL-25 allows collaborative research, multi-
centered in daily practice throughout Europe. This cross-sectional tool could allow transversal 
research between psychiatry and primary care. Nevertheless its translation into most European 
languages should be carefully undertaken, which is now the main task of the research group. 
The group will take great care, as the process involves a self-administrated questionnaire, that 
the general population can easily understand the tool language. 
 
Our methodology had limitations that we took into account and controlled.  
The experts’ panel quality was important for the quality level of the RAM. All experts were 
researchers, FPs and fluent in English. The panel conformed to the requirements of variability 
in culture, language and practice. 4 families of language were represented: Germanic, Slavic, 
Hellenic and Romance. The panel size was sufficient (7 to 15 experts) [19].The deadlines for 
the Delphi rounds were short in order to block communication between experts. Each 
judgment was performed blind, as far as possible[48]. In order to reduce information bias, 
each expert received a record combining all bibliographic sources of the data provided. 
The reliability data were mainly based on Cronbach's alpha values. Those values were 
extracted using an additional literature rapid review inducing an information bias. A 
systematic literature review could have been more discriminating but that was not necessary 
for the RAM. 
The tools found in literature were not anonymized during any of the procedure. The judgment 
of each expert could possibly take into account his knowledge or practice. The experts’ 
opportunity for debate during meetings controlled this confusion bias, in line with the RAM 
instructions. 
 
Conclusion:  
 
We recommend the HSCL- 25 ais the best possible tool, in terms of efficiency, reliability and 
usability, to diagnose depression within European primary care practice in a research 
perspective. Its translation into many European languages will allow collaborative research. 
The research group will carefully undertake those translations. Its application in practice is 
possible in English but will have to be demonstrated (following translation) in the translated 
languages. 
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EGPRN - European General Practice Research Network   
SRL – Systematic Review of literature 
RAND – Research And Development 
RAM – RAND Appropriateness Method 
RAND/UCLA – Research and Development / University of California Los Angeles 
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PPV – Positive Predictive Value 
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